Clinical Trials Directory

Trials / Completed

CompletedNCT02808611

Influence of Propranolol on Conditioned Pain Modulation

Konditionerende Smertestimuli - Sammenligning af Forskellige Test og Konditioneringsmodaliteter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Kristian Kjær Petersen · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

An extensive amount of studies indicate that conditioned pain modulation (CPM) test paradigms can be of use to evaluate the efficacy of the endogenous pain inhibition pathway in healthy controls and pain patients. A number of studies indicate that the autonomic nervous system (ANS) responds to painful stimulation by parasympathetic activity withdrawal and up-regulation of sympathetic activity (flight-or-fight mode), but it remains unknown whether these responses predict individual pain susceptibility or CPM efficacy and whether different pain modalities evoke different physiological stress responses, i.e. do individuals with low pain tolerance exhibit more vigorous ANS responses when subjected to controlled acute pain stimuli, and do high ANS responsiveness to pain coincide with altered psychophysical pain levels/CPM efficacy. This study aims to investigate the effect of ANS responsiveness on CPM paradigms and to investigate if an exogenous, pharmaceutically induced decrease in the sympathetic drive of the ANS will yield decreased CPM efficacy.

Conditions

Interventions

TypeNameDescription
DRUGpropranololReduction of the ANS response
DRUGPlacebo

Timeline

Start date
2016-07-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2016-06-22
Last updated
2017-06-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02808611. Inclusion in this directory is not an endorsement.